Biocryst Pharmaceuticals (BCRX)
NASDAQ:BCRX
Holding BCRX?
Track your performance easily

BioCryst (BCRX) Cash flow

2,138 Followers

BioCryst Cash Flow

BCRX's free cash flow for Q3 2024 was $8.19M. For the 2024 fiscal year, BCRX's free cash flow was decreased by $65.89M and operating cash flow was $8.24M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -55.73M$ -95.14M$ -161.85M$ -142.16M$ -133.10M$ -89.58M
Investing Cash Flow
$ 6.32M$ -131.50M$ -128.24M$ 15.80M$ -6.86M$ 77.93M
Financing Cash Flow
$ -4.91M$ 32.48M$ 88.03M$ 359.67M$ 300.59M$ 99.10M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 377.85M$ 112.45M$ 306.24M$ 507.73M$ 276.36M$ 115.72M
Income Tax Paid Supplemental Data
$ 2.66M$ 1.43M$ 3.54M---
Interest Paid Supplemental Data
$ 42.38M$ 22.14M----
Issuance Of Capital Stock
$ 371.00K$ 342.00K$ 190.00K$ 50.00M$ 93.28M$ 58.50M
Issuance Of Debt
$ -2.51M$ 25.98M$ 73.07M-$ 67.45M$ 19.48M
Repayment Of Debt
$ -2.51M$ -274.02M--$ -52.42M-
Free Cash Flow
$ -56.73M$ -97.31M$ -163.20M$ -144.54M$ -133.61M$ -89.93M
Domestic Sales
------
Foreign Sales
------
Currency in USD

BioCryst Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis